BIBO3304
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


BIBO3304
Description:
BIBO3304, a chemical probe, is a potent, orally active, and selective neuropeptide Y (NPY) Y1 receptor antagonist, with subnanomolar affinity for both the human and the rat Y1 receptor (IC50=0.38 and 0.72 nM, respectively) [1].UNSPSC:
12352005Hazard Statement:
H302, H315, H319, H335Target:
Neuropeptide Y ReceptorType:
Reference compoundRelated Pathways:
GPCR/G Protein; Neuronal SignalingApplications:
Metabolism-protein/nucleotide metabolismField of Research:
Metabolic DiseaseAssay Protocol:
https://www.medchemexpress.com/bibo3304.htmlConcentration:
10mMPurity:
99.96Solubility:
DMSO : 100 mg/mL (ultrasonic)Smiles:
O=C(N[C@@H](C(NCC1=CC=C(CNC(N)=O)C=C1)=O)CCCNC(N)=N)C(C2=CC=CC=C2)C3=CC=CC=C3.O=C(O)C(F)(F)FMolecular Formula:
C31H36F3N7O5Molecular Weight:
643.66Precautions:
H302, H315, H319, H335References & Citations:
[1]Wieland HA, et al. Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents. Br J Pharmacol. 1998 Oct;125 (3) :549-55.|[2]Loh K, et al. Inhibition of Y1 receptor signaling improves islet transplant outcome. Nat Commun. 2017 Sep 8;8 (1) :490.Shipping Conditions:
Blue IceStorage Conditions:
-20°C (Powder, sealed storage, away from moisture)Scientific Category:
Reference compound1Clinical Information:
No Development ReportedIsoform:
NPY Y1 receptorCAS Number:
[191868-14-1]
